Recent Advances of Angiotensin-(1-7) for the Treatment of Acute Respiratory Distress Syndrome

LIU Tian,CHEN Qiu-hua,DONG Liang,QIU Hai-bo
DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2010.023.015
2010-01-01
Abstract:It has been demonstrated that renin-angiotensin system (RAS)was involved in the pathogenesis of acute respiratory distress syndrome (ARDS). Angiotensin Ⅱ (Ang Ⅱ ), which is the main effector of RAS,could activate pulmonary inflammation through its receptor ATIR in ARDS. While recent findings has suggested that Angtensin-(1-7)[Ang-(1-7)],the endougenous antagonist of Ang Ⅱ in RAS,could counter-regulate some pathological changes of Ang Ⅱ such as inflammation, fibrosis and pulmonary hypertension. These results indicate that Ang-(1-7) may protect from ARDS. In this review,we will focus on the recent findings related to the potential beneficial aspects of Ang-(1-7) in ARDS.
What problem does this paper attempt to address?